KMRC-20Homo sapiens (Human)Cancer cell line

Also known as: KMRC20

🤖 AI SummaryBased on 6 publications

Quick Overview

Human renal cell carcinoma cell line with potential for research in cancer genomics and drug sensitivity.

Detailed Summary

KMRC-20 is a human renal cell carcinoma (RCC) cell line derived from kidney tissue. It is utilized in studies focusing on the genomic characteristics of RCC, particularly in understanding the molecular mechanisms underlying clear cell RCC (ccRCC) and its subtypes. Research involving KMRC-20 has contributed to the identification of genetic alterations, such as copy number variations and mutations, which are critical for understanding tumor biology and developing targeted therapies. The cell line is part of the Cancer Cell Line Encyclopedia (CCLE) and has been analyzed for its response to various anticancer drugs, providing insights into drug sensitivity and resistance. Additionally, KMRC-20 has been used to investigate the role of specific genes, such as SAV1, in the pathogenesis of high-grade ccRCC, highlighting its importance in cancer research.

Research Applications

Genomic profiling of renal cell carcinomaDrug sensitivity and resistance studiesInvestigation of genetic mutations in ccRCCAnalysis of copy number variations in cancerStudy of SAV1 gene function in tumor progression

Key Characteristics

Part of the CCLE databaseUsed in studies of ccRCC molecular mechanismsRelevant for understanding tumor heterogeneityUtilized in drug response profiling
Generated on 6/19/2025

Basic Information

Database IDCVCL_2986
SpeciesHomo sapiens (Human)
Tissue SourceKidney[UBERON:UBERON_0002113]

Donor Information

Age CategoryUnknown
SexUnknown

Disease Information

DiseaseClear cell renal carcinoma
LineageKidney
SubtypeRenal Clear Cell Carcinoma
OncoTree CodeCCRCC

DepMap Information

Source TypeHSRRB
Source IDACH-000250_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53c.672+1G>THomozygousSplice donor mutationUnknown, Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,12
D13S317
8
D16S539
9,11
D18S51
14,16
D19S433
13,13.2
D21S11
28,30
D2S1338
24
D3S1358
15
D5S818
9,11
D7S820
10,11
D8S1179
12,13
FGA
21,22
Penta D
10,13
Penta E
10,16
TH01
7,9
TPOX
11
vWA
14,17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.

van 't Veer L.J., Butte A.J., Goldstein T., Sirota M.

Nat. Commun. 10:3574.1-3574.11(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.

Hsieh J.J.-D., Hakimi A.A.

Nat. Commun. 8:15165.1-15165.10(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma.

Mimata H., Seto M., Moriyama M.

BMC Cancer 11:523.1-523.10(2011).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).